Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48709
Campo DC Valoridioma
dc.contributor.authorAragon Sanchez, Javieren_US
dc.contributor.authorCabrera-Galván, J. J.en_US
dc.contributor.authorQuintana-Marrero, Y.en_US
dc.contributor.authorHernández-Herrero, M. J.en_US
dc.contributor.authorLázaro-Martínez, J. L.en_US
dc.contributor.authorGarcía-Morales, E.en_US
dc.contributor.authorBeneit-Montesinos, J. V.en_US
dc.contributor.authorArmstrong, D. G.en_US
dc.date.accessioned2018-11-24T00:15:26Z-
dc.date.available2018-11-24T00:15:26Z-
dc.date.issued2008en_US
dc.identifier.issn0012-186Xen_US
dc.identifier.urihttp://hdl.handle.net/10553/48709-
dc.description.abstractAims/hypothesis: We analysed the factors that determine the outcomes of surgical treatment of osteomyelitis of the foot in diabetic patients given early surgical treatment within 12 h of admission and treated with prioritisation of foot-sparing surgery and avoidance of amputation. Methods: A consecutive series of 185 diabetic patients with foot osteomyelitis and histopathological confirmation of bone involvement were followed until healing, amputation or death. Results: Probing to bone was positive in 175 cases (94.5%) and radiological signs of osteomyelitis were found in 157 cases (84.8%). Staphylococcus aureus was the organism isolated in the majority of cultures (51.3%), and in 35 cases (36.8%) it proved to be methicillin-resistant. The surgical treatment performed included 91 conservative surgical procedures, which were defined as those where no amputation of any part of the foot was undertaken (49.1%). A total of 94 patients received some degree of amputation, consisting of 79 foot-level (minor) amputations (42.4%) and 15 major amputations (8%). Five patients died during the perioperative period (2.7%). Histopathological analysis revealed 94 cases (50.8%) of acute osteomyelitis, 43 cases (23.2%) of chronic osteomyelitis, 45 cases (24.3%) of acute exacerbation of chronic osteomyelitis and three remaining cases (1.6%) designated as 'other'. The risks of failure in the case of conservative surgery were exposed bone, the presence of ischaemia and necrotising soft tissue infection. Conclusions/interpretation: Conservative surgery without local or high-level amputation is successful in almost half of the cases of diabetic foot osteomyelitis. Prospective trials should be undertaken to determine the relative roles of conservative surgery versus other approaches.en_US
dc.languageengen_US
dc.relation.ispartofDiabetologia (Berlin)en_US
dc.sourceDiabetologia[ISSN 0012-186X],v. 51, p. 1962-1970 (Noviembre 2008)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320502 Endocrinologíaen_US
dc.subject.otherBone infectionen_US
dc.subject.otherDiabetic footen_US
dc.subject.otherDiabetic foot infectionsen_US
dc.subject.otherFoot ulceren_US
dc.subject.otherNecrotisingen_US
dc.subject.otherNecrotizingen_US
dc.subject.otherOsteomyelitisen_US
dc.titleOutcomes of surgical treatment of diabetic foot osteomyelitis: A series of 185 patients with histopathological confirmation of bone involvementen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s00125-008-1131-8en_US
dc.identifier.scopus53549124104-
dc.contributor.authorscopusid6507768519-
dc.contributor.authorscopusid6602257053-
dc.contributor.authorscopusid24598202200-
dc.contributor.authorscopusid24597529900-
dc.contributor.authorscopusid18434633300-
dc.contributor.authorscopusid18434169300-
dc.contributor.authorscopusid6504143692-
dc.contributor.authorscopusid7404407396-
dc.description.lastpage1970en_US
dc.description.firstpage1962en_US
dc.relation.volume51en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.date.coverdateNoviembre 2008en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr6,418-
dc.description.jcrqQ1-
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-6307-5040-
crisitem.author.orcid0000-0002-4184-6403-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameAragón Sanchez,Javier-
crisitem.author.fullNameCabrera Galván,Juan José-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

181
actualizado el 30-mar-2025

Citas de WEB OF SCIENCETM
Citations

151
actualizado el 30-mar-2025

Visitas

57
actualizado el 23-may-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.